Entera Bio earnings were -$9.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ENTX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.4M, down 21.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ENTX reported annual earnings of -$9.5M, with 7.3% growth. The next ENTX earnings date is May 8, 2025.
On ENTX's earnings call on Invalid Date, Entera Bio (NASDAQ: ENTX) reported Q4 2024 earnings per share (EPS) of -$0.06, up 14.29% year over year. Total ENTX earnings for the quarter were -$2.36 million. In the same quarter last year, Entera Bio's earnings per share (EPS) was -$0.07.
The next ENTX earnings call is Invalid Date. Add ENTX to your watchlist to be reminded of Entera Bio's next earnings date.
What was ENTX's earnings growth in the past year?
As of Entera Bio's earnings date in Invalid Date, Entera Bio's earnings has grown year over year. ENTX earnings in the past year totalled -$9.54 million.
Is Entera Bio profitable or losing money?
As of the last Entera Bio earnings report, Entera Bio is currently losing money. Entera Bio's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$9.54 million, a 7.33% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.